Pseudomonas maltophilia causing heroin-associated infective endocarditis

Area of Science:

• Infectious Diseases
• Cardiology
• Antimicrobial Resistance

Background:

• Endocarditis is a serious infection of the heart lining, often associated with intravenous drug abuse and abnormal heart valves.
• Pseudomonas maltophilia (now known as Stenotrophomonas maltophilia) is an opportunistic pathogen that can cause severe infections.
• This pathogen exhibits significant in vitro resistance to many commonly used antimicrobial agents.

Observation:

• Three cases of Pseudomonas maltophilia endocarditis were identified in patients with a history of intravenous drug abuse.
• All affected patients presented with pre-existing cardiac abnormalities, including prosthetic and rheumatic heart valves.
• A notable characteristic observed was the pathogen's inherent resistance to standard antimicrobial treatments.

Findings:

• Successful treatment was achieved in all three patients, demonstrating the possibility of overcoming this challenging infection.
• Two patients were treated with synergistic antibiotic combinations, highlighting the potential of multi-drug regimens.
• One patient developed plasmid-mediated resistance to amikacin sulfate during therapy, underscoring the dynamic nature of antimicrobial resistance.
• Patients with prosthetic valves required a combination of surgical intervention and antibiotic therapy for successful outcomes.

Implications:

• These findings suggest that Pseudomonas maltophilia can be a significant cause of endocarditis in intravenous drug users with valvular heart disease.
• The study emphasizes the need for careful antimicrobial selection and monitoring due to the pathogen's resistance profile.
• Synergistic antibiotic combinations and surgical intervention may be crucial for managing complex cases, particularly those involving prosthetic valves.